Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 76 | 75 | -2,093 | 72 | -334 |
| Depreciation Amortization | 584 | 277 | 1,160 | 579 | 360 |
| Accounts receivable | -1,237 | -263 | -670 | -334 | 425 |
| Accounts payable and accrued liabilities | 568 | -465 | 333 | -913 | -341 |
| Other Working Capital | -754 | -1,039 | 2,610 | -1,193 | -333 |
| Other Operating Activity | 927 | 700 | 1,565 | 2,149 | 304 |
| Operating Cash Flow | $164 | $-715 | $2,905 | $360 | $81 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,224 | -718 | -2,220 | -693 | -522 |
| Other Investing Activity | 92 | 92 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,132 | $-626 | $-2,220 | $-693 | $-522 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -115 | -58 | -35 | -51 | -14 |
| Common Stock Issued | 1,294 | N/A | 4,455 | 429 | 2 |
| Financing Cash Flow | $1,179 | $-58 | $4,420 | $378 | $-12 |
| Beginning Cash Position | 8,342 | 8,342 | 3,237 | 3,237 | 3,237 |
| End Cash Position | 8,553 | 6,943 | 8,342 | 3,282 | 2,784 |
| Net Cash Flow | $211 | $-1,399 | $5,105 | $45 | $-453 |
| Free Cash Flow | |||||
| Operating Cash Flow | 164 | -715 | 2,905 | 360 | 81 |
| Capital Expenditure | -1,224 | -718 | -2,220 | -693 | -522 |
| Free Cash Flow | -1,060 | -1,433 | 685 | -333 | -441 |